INBX Operating Cash Flow (Statement)
Inhibrx Biosciences Inc · Operating Cash Flow (Statement)
INBX Operating Cash Flow (Statement)
Latest reported-$131.89Mperiod ending
INBX TTM Cash from Operations (-$29.05M → -$131.89M)
TTM operating cash flow (statement)
High-resolution chart · PNG
INBX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -131,889,000 | |
| -131,925,000 | |
| -129,794,000 | |
| -143,392,000 | |
| -139,849,000 | |
| -167,254,000 | |
| -194,409,000 | |
| -207,510,000 | |
| -231,474,000 | |
| -216,415,000 | |
| -180,304,000 | |
| -154,083,000 | |
| -130,676,000 | |
| -115,299,000 | |
| -115,301,000 | |
| -107,321,000 | |
| -90,158,000 | |
| -85,616,000 | |
| -80,323,000 | |
| -73,092,000 | |
| -73,299,000 | |
| -62,228,000 | |
| -47,968,000 | |
| -44,521,000 | |
| -31,412,000 | |
| -33,890,000 | |
| -32,079,000 | |
| -27,061,000 | |
| -39,295,000 | |
| -27,622,000 | |
| -29,054,000 |